SocraTec R&D Concepts in Drug Research and Development GmbH

Gynecological Health

SocraTec R&D Concepts in Drug Research and Development GmbH is involved in clinical research on vaginal atrophy, with attention to postmenopausal vaginal epithelium changes and local estrogen-related treatment effects.

  • Postmenopausal vaginal tissue health
  • Vaginal epithelial cytology
  • Vaginal pH

The sponsor’s research activity in this area centers on urogenital symptoms associated with menopause and the therapeutic use of locally delivered hormone-based approaches.

Contraception

The sponsor also funds studies in contraceptive medicine, with a focus on maintaining ovulation inhibition under conditions of intentional dosing irregularity.

  • Levonorgestrel progestin-only pill
  • Ovulation suppression
  • Intake error resilience

This area reflects interest in hormonal contraception and the reliability of oral contraceptive protection during delayed tablet intake.

Hormone-Based Local Therapy

Clinical work supported by the sponsor includes evaluation of locally acting estriol delivery systems for women’s health, with emphasis on treatment-related changes in the vaginal environment.

  • Vaginal ring drug delivery
  • Local estrogen therapy
  • Menopause-related vaginal symptoms

These studies place the sponsor within therapeutic development for topical hormonal treatments in gynecological care.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Estriol Vaginal Ring for Treating Vaginal Atrophy in Postmenopausal Women

    Not recruiting

    2 1
    Investigated drugs:
    Germany
  • Study on Ovulation Inhibition with Levonorgestrel Tablets for Contraception in Women with Intentional Intake Errors

    Not recruiting

    2 1 1
    Investigated drugs:
    Germany